Vericel Corporation
Vericel Corporation (VCEL) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · VCEL · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
23
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Vericel Corporation insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
VCEL insider buying and selling by quarter
VCEL insider selling · VCEL insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · VCEL ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
VCEL executive sell shares · VCEL board member insider trading · VCEL insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 2, 2026 | Hopper Jonathan Mark Chief Medical Officer | Option | 4,375 | $73K | Form 4 |
| Jun 2, 2026 | Hopper Jonathan Mark Chief Medical Officer | Sale | 4,375 | $153K | Form 4 |
| May 13, 2026 | MCLAUGHLIN KEVIN F Director | Option | 3,500 | $9K | Form 4 |
| May 13, 2026 | MCLAUGHLIN KEVIN F Director | Option | 3,500 | $46K | Form 4 |
| May 13, 2026 | MCLAUGHLIN KEVIN F Director | Sale | 3,500 | $115K | Form 4 |
| May 13, 2026 | MCLAUGHLIN KEVIN F Director | Sale | 3,500 | $115K | Form 4 |
| May 11, 2026 | Wotton Paul K Director | Sale | 2,500 | $83K | Form 4 |
| May 11, 2026 | Wotton Paul K Director | Sale | 7,500 | $245K | Form 4 |
| May 7, 2026 | Mara Joseph Anthony Jr CFO | Sale | 5,000 | $203K | Form 4 |
| May 6, 2026 | SIEGAL JONATHAN PAO | Sale | 3,433 | $130K | Form 4 |
| May 7, 2026 | SIEGAL JONATHAN PAO | Sale | 1,422 | $58K | Form 4 |
| Apr 29, 2026 | MCLAUGHLIN KEVIN F Director | Option | 3,200 | — | Form 4 |
| Apr 29, 2026 | Rubino Alan L Director | Option | 3,200 | — | Form 4 |
| Apr 29, 2026 | Hagen Heidi Director | Option | 3,200 | — | Form 4 |
| Apr 29, 2026 | Wotton Paul K Director | Option | 3,200 | — | Form 4 |
| Apr 29, 2026 | WRIGHT LISA Director | Option | 3,200 | — | Form 4 |
| Apr 29, 2026 | ZERBE ROBERT L MD Director | Option | 3,200 | — | Form 4 |
| Apr 2, 2026 | Hopper Jonathan Mark Chief Medical Officer | Option | 3,472 | $38K | Form 4 |
| Apr 2, 2026 | Hopper Jonathan Mark Chief Medical Officer | Sale | 3,472 | $122K | Form 4 |
| Mar 25, 2026 | Rubino Alan L Director | Option | 15,000 | $41K | Form 4 |
| Mar 23, 2026 | Hagen Heidi Director | Option | 15,000 | $41K | Form 4 |
| Mar 23, 2026 | Hagen Heidi Director | Sale | 15,000 | $486K | Form 4 |
| Mar 2, 2026 | Flynn Sean C. Chief Legal Officer | Option | 15,000 | $244K | Form 4 |
| Mar 2, 2026 | Flynn Sean C. Chief Legal Officer | Sale | 6,421 | $223K | Form 4 |
| Mar 2, 2026 | Flynn Sean C. Chief Legal Officer | Sale | 15,000 | $530K | Form 4 |
Hopper Jonathan Mark
Chief Medical Officer
Date
Jun 2
Shares
4,375
Price
$16.66
Value
$73K
Hopper Jonathan Mark
Chief Medical Officer
Date
Jun 2
Shares
4,375
Price
$35.00
Value
$153K
Hopper Jonathan Mark
Chief Medical Officer
Date
Apr 2
Shares
3,472
Price
$10.95
Value
$38K
Hopper Jonathan Mark
Chief Medical Officer
Date
Apr 2
Shares
3,472
Price
$35.00
Value
$122K
Flynn Sean C.
Chief Legal Officer
Date
Mar 2
Shares
15,000
Price
$16.25
Value
$244K
Flynn Sean C.
Chief Legal Officer
Date
Mar 2
Shares
15,000
Price
$35.36
Value
$530K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About VCEL insider trading
VCEL insider trades
Vericel Corporation (VCEL) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Hopper Jonathan Mark (Chief Medical Officer), Flynn Sean C. (Chief Legal Officer), SIEGAL JONATHAN (PAO). Over the past 12 months, 5 insiders have filed transactions with the SEC. VCEL insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Vericel Corporation's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
VCEL insider trading · 5 questionsThe insiders of Vericel Corporation (VCEL) include executives and directors such as Hopper Jonathan Mark (Chief Medical Officer), Flynn Sean C. (Chief Legal Officer), SIEGAL JONATHAN (PAO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026